Stay updated on First-in-Human Study of EYP-1901 in wAMD Clinical Trial
Sign up to get notified when there's something new on the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page.

Latest updates to the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new Locations section has been added, listing participating sites by state (Arizona, California, Florida, Massachusetts, North Carolina, Pennsylvania, Texas). The page version has been updated to v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.9%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page shows an updated revision line: Revision: v3.3.2, replacing the previous v3.3.1. This appears to be a technical revision with no changes to study data or page content.SummaryDifference0.1%

- Check47 days agoChange DetectedPublications section updated to indicate entries are auto-filled from PubMed and a revision tag (v3.3.1) was added.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding lapse notice from the page.SummaryDifference0.4%

- Check69 days agoChange DetectedNo significant changes to core content such as study details, eligibility criteria, locations, or outcomes; the changes appear to be minor visual or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange Detected- Added a government funding notice about potential delays and operating status, and a link to cc.nih.gov and opm.gov for status updates. - Bumped revision version from v3.1.0 to v3.2.0.SummaryDifference5%

Stay in the know with updates to First-in-Human Study of EYP-1901 in wAMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the First-in-Human Study of EYP-1901 in wAMD Clinical Trial page.